Childhood-Onset Lupus Nephritis Linked With Adverse Outcomes
Early diagnosis and treatment of childhood-onset systemic lupus erythematosus is important to prevent lupus nephritis outcomes such as end-stage kidney disease.
Early diagnosis and treatment of childhood-onset systemic lupus erythematosus is important to prevent lupus nephritis outcomes such as end-stage kidney disease.
With further validation, the artificial neural network may be used in clinical practice for lupus nephritis management.
Both weight-based and non-weight-based low-dose HCQ associated with increased hospitalizations for SLE
Belimumab treatment continued to protect the kidneys in adults with active lupus nephritis.
One study focused on patients with severe lupus nephritis, who are at greatest risk for kidney failure.
In a 5-year follow-up study, researchers identified the characteristics associated with cardiac function in patients with systemic lupus erythematosus.
In a study of 121 patients with lupus nephritis on dialysis, 26.4% experienced an SLE flare at a median of 17 months after dialysis initiation.
Risk increased progressively with the number of autoimmune diseases present and with younger age
Researchers compared the QRISK3 and the adjusted Global AntiPhospholipid Syndrome Score in patients with systemic lupus erythematosus to assess their risk of developing cardiovascular disease.
Most secondary end points did not support the results of the analysis for the primary end point